Cyclacel Pharmaceuticals ...

6.59
0.09 (1.38%)
At close: Feb 10, 2025, 12:32 PM
6.60
0.15%
After-hours Feb 10, 2025, 04:00 PM EST
undefined%
Bid 5.93
Market Cap 3.47M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.047
PE Ratio (ttm) -3.22
Forward PE n/a
Analyst n/a
Ask 7.27
Volume 430
Avg. Volume (20D) 4,908
Open 6.60
Previous Close 6.50
Day's Range 6.59 - 7.22
52-Week Range 5.20 - 21.47
Beta undefined

About CYCCP

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-...

Industry Biotechnology
Sector Healthcare
IPO Date Nov 30, 2005
Employees 12
Stock Exchange NASDAQ
Ticker Symbol CYCCP
3 months ago
+0%
Cyclacel Pharmaceuticals shares are trading higher... Unlock content with Pro Subscription